Iwatsuki S, Dvorchik I, Madariaga J R, Marsh J W, Dodson F, Bonham A C, Geller D A, Gayowski T J, Fung J J, Starzl T E
Department of Surgery, the Thomas E Starzl Transplantation Institute, University of Pittsburgh Medical Center, PA 15213, USA.
J Am Coll Surg. 1999 Sep;189(3):291-9. doi: 10.1016/s1072-7515(99)00089-7.
Hepatic resection for metastatic colorectal cancer provides excellent longterm results in a substantial proportion of patients. Although various prognostic risk factors have been identified, there has been no dependable staging or prognostic scoring system for metastatic hepatic tumors.
Various clinical and pathologic risk factors were examined in 305 consecutive patients who underwent primary hepatic resections for metastatic colorectal cancer. Survival rates were estimated by the Cox proportional hazards model using the equation: S(t) = [So(t)]exp(R-Ro), where So(t) is the survival rate of patients with none of the identified risk factors and Ro = 0.
Preliminary multivariate analysis revealed that independently significant negative prognosticators were: (1) positive surgical margins, (2) extrahepatic tumor involvement including the lymph node(s), (3) tumor number of three or more, (4) bilobar tumors, and (5) time from treatment of the primary tumor to hepatic recurrence of 30 months or less. Because the survival rates of the 62 patients with positive margins or extrahepatic tumor were uniformly very poor, multivariate analysis was repeated in the remaining 243 patients who did not have these lethal risk factors. The reanalysis revealed that independently significant poor prognosticators were: (1) tumor number of three or more, (2) tumor size greater than 8 cm, (3) time to hepatic recurrence of 30 months or less, and (4) bilobar tumors. Risk scores (R) for tumor recurrence of the culled cohort (n = 243) were calculated by summation of coefficients from the multivariate analysis and were divided into five groups: grade 1, no risk factors (R = 0); grade 2, one risk factor (R = 0.3 to 0.7); grade 3, two risk factors (R = 0.7 to 1.1); grade 4, three risk factors (R= 1.2 to 1.6); and grade 5, four risk factors (R > 1.6). Grade 6 consisted of the 62 culled patients with positive margins or extrahepatic tumor. Kaplan-Meier and Cox proportional hazards estimated 5-year survival rates of grade 1 to 6 patients were 48.3% and 48.3%, 36.6% and 33.7%, 19.9% and 17.9%, 11.9% and 6.4%, 0% and 1.1%, and 0% and 0%, respectively (p < 0.0001).
The proposed risk-score grading predicted the survival differences extremely well. Estimated survival as determined by the Cox proportional hazards model was similar to that determined by the Kaplan-Meier method. Verification and further improvements of the proposed system are awaited by other centers or international collaborative studies.
对转移性结直肠癌进行肝切除可使相当一部分患者获得出色的长期疗效。尽管已确定了各种预后风险因素,但对于转移性肝肿瘤,尚无可靠的分期或预后评分系统。
对305例连续接受转移性结直肠癌原发性肝切除的患者的各种临床和病理风险因素进行了研究。使用公式S(t) = [So(t)]exp(R - Ro),通过Cox比例风险模型估计生存率,其中So(t)是无任何已确定风险因素患者的生存率,Ro = 0。
初步多变量分析显示,独立的显著负性预后因素为:(1)手术切缘阳性;(2)肝外肿瘤累及包括淋巴结;(3)肿瘤数量为三个或更多;(4)双侧肿瘤;(5)从原发性肿瘤治疗至肝复发的时间为30个月或更短。由于62例切缘阳性或有肝外肿瘤患者的生存率普遍非常低,因此对其余243例无这些致命风险因素的患者重复进行多变量分析。重新分析显示,独立的显著不良预后因素为:(1)肿瘤数量为三个或更多;(2)肿瘤大小大于8 cm;(3)至肝复发的时间为30个月或更短;(4)双侧肿瘤。通过多变量分析系数求和计算剔除队列(n = 243)的肿瘤复发风险评分(R),并分为五组:1级,无风险因素(R = 0);2级,一个风险因素(R = 0.3至0.7);3级,两个风险因素(R = 0.7至1.1);4级,三个风险因素(R = 1.2至1.6);5级,四个风险因素(R > 1.6)。6级包括62例切缘阳性或有肝外肿瘤的剔除患者。Kaplan-Meier法和Cox比例风险模型估计的1至6级患者5年生存率分别为48.3%和48.3%、36.6%和33.7%、19.9%和17.9%、11.9%和6.4%、0%和1.1%、0%和0%(p < 0.0001)。
所提出的风险评分分级能很好地预测生存差异。Cox比例风险模型确定的估计生存率与Kaplan-Meier法确定的相似。其他中心或国际合作研究有待对所提出的系统进行验证和进一步改进。